Eli Lilly and Cipla enter into a strategic partnership in India to enhance access to Lilly’s key diabetes products Kumar Jeetendra | October 4, 2021 Mumbai, Oct 04 2021: Eli Lilly and Company (India) Pvt. Ltd. (hereinafter referred as “Lilly”), headquartered in Gurgaon, is a wholly owned subsidiary of Eli Lilly and Company, a global biopharmaceutical company headquartered in Indianapolis, USA, and Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced its strategic partnership in …
